{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:18:57Z","timestamp":1768565937592,"version":"3.49.0"},"posted":{"date-parts":[[2023,7,30]]},"group-title":"Intensive Care and Critical Care Medicine","reference-count":49,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Over one-third of patients with septic shock have adjunctive vasopressors added to first-line vasopressors. However, no randomized trial has detected improved mortality with adjunctive vasopressors. Published systematic reviews and meta-analysis have sought to inform the use of adjunctive vasopressors, yet each published review has limitations that hinder its interpretation. This review aims to overcome the limitations of previous reviews by systematically synthesizing the direct evidence for adjunctive vasopressor therapy use in adult patients with septic shock.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We will conduct a systematic review and meta-analysis of randomized controlled trials evaluating adjunctive vasopressors (vasopressin analogues, angiotensin II, hydroxocobalamin, methylene blue, and catecholamine analogues) in adult patients with septic shock. Relevant studies will be identified through comprehensive searches of MEDLINE, Embase, CENTRAL, and reference lists of previous systematic reviews. Only randomized trials comparing adjunctive vasopressors (&gt;75% of subjects on vasopressors at enrollment) to standard care vasopressors in adults with septic shock (&gt;75% of subjects having septic shock) will be included. Titles and abstracts will be screened, full-text articles assessed for eligibility, and data extracted from included studies. Outcomes of interest include short-term mortality, intermediate-term mortality, kidney replacement therapy, digital\/peripheral ischemia, and venous thromboembolism. Pairwise meta-analysis using a random-effects model will be utilized to estimate the risk ratio for the outcomes. Risk of bias will be adjudicated with the Cochrane Risk of Bias 2 tool, and GRADE will be used to rate the certainty of the body of evidence.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Although adjunctive vasopressors are commonly used in patients with septic shock their effect on patient-important outcomes is unclear. This study is planned to use rigorous systematic review methodology, including strict adhere to established guidelines, in order to overcome limitations of previously-published reviews and inform clinical practice and treatment guidelines for the use of adjunctive vasopressors in adults with septic shock.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Systematic review registration<\/jats:title>\n                  <jats:p>PROSPERO CRD4202327984<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.07.29.23293364","type":"posted-content","created":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T14:20:15Z","timestamp":1690726815000},"source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive Vasopressors in Patients with Septic Shock: Protocol for a Systematic Review and Meta-Analysis"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0420-0320","authenticated-orcid":false,"given":"Seth R.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany D.","family":"Bissell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Dugar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen L.","family":"Sacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Siuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Schleicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidula","family":"Vachharajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023080112550714000_2023.07.29.23293364v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7"},{"key":"2023080112550714000_2023.07.29.23293364v1.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.5804"},{"key":"2023080112550714000_2023.07.29.23293364v1.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"2023080112550714000_2023.07.29.23293364v1.4","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000005337"},{"issue":"10","key":"2023080112550714000_2023.07.29.23293364v1.5","first-page":"1760","article-title":"Epidemiology of Vasopressin Use for Adults with Septic Shock","volume":"13","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"2023080112550714000_2023.07.29.23293364v1.6","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1513\/AnnalsATS.202102-196OC","article-title":"Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States","volume":"18","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2023080112550714000_2023.07.29.23293364v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067373"},{"key":"2023080112550714000_2023.07.29.23293364v1.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10485"},{"key":"2023080112550714000_2023.07.29.23293364v1.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.14607"},{"key":"2023080112550714000_2023.07.29.23293364v1.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704154"},{"key":"2023080112550714000_2023.07.29.23293364v1.11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jcrc.2018.12.007","article-title":"Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data","volume":"50","year":"2019","journal-title":"J Crit Care"},{"issue":"3","key":"2023080112550714000_2023.07.29.23293364v1.12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12630-019-01546-x","article-title":"Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock","volume":"67","year":"2020","journal-title":"Can J Anaesth"},{"key":"2023080112550714000_2023.07.29.23293364v1.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129305"},{"key":"2023080112550714000_2023.07.29.23293364v1.14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcrc.2016.08.010","article-title":"The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials","volume":"37","year":"2017","journal-title":"J Crit Care"},{"issue":"1","key":"2023080112550714000_2023.07.29.23293364v1.15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40560-020-00500-0","article-title":"Non-catecholamine vasopressors in the treatment of adult patients with septic shock\u2014evidence from meta-analysis and trial sequential analysis of randomized clinical trials","volume":"8","year":"2020","journal-title":"J Intensive Care"},{"issue":"6","key":"2023080112550714000_2023.07.29.23293364v1.16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","year":"2019","journal-title":"Intensive Care Med"},{"issue":"1","key":"2023080112550714000_2023.07.29.23293364v1.17","first-page":"42","article-title":"Methylene blue as a vasopressor: a meta-analysis of randomised trials","volume":"15","year":"2013","journal-title":"Crit Care Resusc"},{"issue":"18","key":"2023080112550714000_2023.07.29.23293364v1.18","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis","volume":"319","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"2023080112550714000_2023.07.29.23293364v1.19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/phar.2105","article-title":"Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock","volume":"38","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"12","key":"2023080112550714000_2023.07.29.23293364v1.20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.ccm.0000510024.07609.07","article-title":"Norepinephrine and Vasopressin vs Norepinephrine Alone for Septic Shock: Randomized Controlled Trial","volume":"44","year":"2016","journal-title":"Crit Care Med"},{"key":"2023080112550714000_2023.07.29.23293364v1.21","doi-asserted-by":"publisher","DOI":"10.1186\/cc7990"},{"key":"2023080112550714000_2023.07.29.23293364v1.22","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001434"},{"issue":"1","key":"2023080112550714000_2023.07.29.23293364v1.23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jrsm.1064","article-title":"Issues relating to confounding and meta-analysis when including non-randomized studies in systematic reviews on the effects of interventions","volume":"4","year":"2013","journal-title":"Res Synth Methods"},{"key":"2023080112550714000_2023.07.29.23293364v1.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2020-111493"},{"issue":"5","key":"2023080112550714000_2023.07.29.23293364v1.25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00134-019-05596-z","article-title":"Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a post hoc analysis","volume":"45","year":"2019","journal-title":"Intensive Care Med"},{"issue":"1","key":"2023080112550714000_2023.07.29.23293364v1.26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","year":"2018","journal-title":"Crit Care"},{"issue":"1","key":"2023080112550714000_2023.07.29.23293364v1.27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future","volume":"22","year":"2018","journal-title":"Crit Care"},{"key":"2023080112550714000_2023.07.29.23293364v1.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647"},{"key":"2023080112550714000_2023.07.29.23293364v1.29","unstructured":"Thomas J , Kneale D , McKenzie JE , Brennan SE , Bhaumik S. Chapter 2: Determining the scope of the review and the questions it will address. In: Higgins JPT , Thomas J , Chandler J , et al. , eds. Cochrane Handbook for Systematic Reviews of Interventions. 6.3 (updated February 2022) ed: Cochrane; 2022."},{"key":"2023080112550714000_2023.07.29.23293364v1.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B"},{"key":"2023080112550714000_2023.07.29.23293364v1.31","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000117317.18092.E4"},{"key":"2023080112550714000_2023.07.29.23293364v1.32","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000298158.12101.41"},{"key":"2023080112550714000_2023.07.29.23293364v1.33","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31827e83af"},{"key":"2023080112550714000_2023.07.29.23293364v1.34","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002255"},{"issue":"2","key":"2023080112550714000_2023.07.29.23293364v1.35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/CCM.0000000000005721","article-title":"Mortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients","volume":"51","year":"2023","journal-title":"Crit Care Med"},{"issue":"1","key":"2023080112550714000_2023.07.29.23293364v1.36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13613-017-0243-z","article-title":"Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review","volume":"7","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"8","key":"2023080112550714000_2023.07.29.23293364v1.37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/phar.2147","article-title":"Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock","volume":"38","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2023080112550714000_2023.07.29.23293364v1.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2023080112550714000_2023.07.29.23293364v1.39","unstructured":"Deeks JJ , Higgins JPT , Altman DJ . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT , Thomas J , Chandler J , et al. , eds. Cochrane Handbook for Systematic Reviews of Interventions. Vol 6.3 (updated February 2022): Cochrane; 2022."},{"key":"2023080112550714000_2023.07.29.23293364v1.40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","article-title":"Vasopressor dose equivalence: A scoping review and suggested formula","volume":"61","year":"2021","journal-title":"J Crit Care"},{"key":"2023080112550714000_2023.07.29.23293364v1.41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135"},{"key":"2023080112550714000_2023.07.29.23293364v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"2023080112550714000_2023.07.29.23293364v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.03.017"},{"key":"2023080112550714000_2023.07.29.23293364v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.04.014"},{"key":"2023080112550714000_2023.07.29.23293364v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.01.012"},{"issue":"12","key":"2023080112550714000_2023.07.29.23293364v1.46","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/CCM.0000000000004568","article-title":"Powering Bias and Clinically Important Treatment Effects in Randomized Trials of Critical Illness","volume":"48","year":"2020","journal-title":"Crit Care Med"},{"issue":"2","key":"2023080112550714000_2023.07.29.23293364v1.47","first-page":"137","article-title":"Protocol and statistical analysis plan for the mega randomised registry trial research program comparing conservative versus liberal oxygenation targets in adults receiving unplanned invasive mechanical ventilation in the ICU (Mega-ROX)","volume":"24","year":"2022","journal-title":"Crit Care Resusc"},{"key":"2023080112550714000_2023.07.29.23293364v1.48","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University and Evidence Prime, 2022. Available from gradepro.org."},{"key":"2023080112550714000_2023.07.29.23293364v1.49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.07.29.23293364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:38:09Z","timestamp":1768505889000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.07.29.23293364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,30]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1101\/2023.07.29.23293364","relation":{},"subject":[],"published":{"date-parts":[[2023,7,30]]},"subtype":"preprint"}}